bromhexine has been researched along with Sclerosis, Systemic in 2 studies
Bromhexine: A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)
bromhexine : A substituted aniline that is 2,4-dibromoaniline which is substituted at position 6 by a [cyclohexyl(methyl)amino]methyl group. It is used (as the monohydrochloride salt) as a mucolytic for the treatment of respiratory disorders associated with productive cough (i.e. a cough characterised by the production of sputum).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Konopik, J | 2 |
| Krs, V | 1 |
2 other studies available for bromhexine and Sclerosis, Systemic
| Article | Year |
|---|---|
[Conservative treatment of chronic lymphedema and sclerotic skin processes].
Topics: Bromhexine; Female; Glycosaminoglycans; Humans; Leg Ulcer; Lymphedema; Male; Scleroderma, Localized; | 1984 |
[Treatment of scleroderma with depolymerizing agents].
Topics: Bromhexine; Female; Humans; Hyaluronoglucosaminidase; Male; Scleroderma, Localized; Scleroderma, Sys | 1982 |